vascular endothelial growth factor (VEGF)
Showing 51 - 75 of >10,000
Low Vision, Neovascular Age-related Macular Degeneration Trial in Baltimore (Vision rehabilitation)
Completed
- Low Vision
- Neovascular Age-related Macular Degeneration
- Vision rehabilitation
-
Baltimore, MarylandWilmer Eye Institute
Dec 13, 2019
End Stage Renal Disease, Hemodialysis Vascular Access Failure Trial (1.25mg bevacizumab, 2.50mg bevacizumab)
Withdrawn
- End Stage Renal Disease
- Hemodialysis Vascular Access Failure
- 1.25mg bevacizumab
- 2.50mg bevacizumab
- (no location specified)
Jul 6, 2020
Vascular Endothelial Factor Gene Polymorphism in Preeclampsia
Completed
- Preeclampsia
- PCR
- Doppler ultrasound
-
Cairo, Beni-Suef, EgyptBeni-Suef University
Mar 24, 2021
Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Bronx, Manhasset, New York (aflibercept)
Terminated
- Stage II Multiple Myeloma
- Stage III Multiple Myeloma
- aflibercept
-
Bronx, New York
- +5 more
Jan 29, 2021
Diabetic Macular Edema, Macular Ischemia, Diabetic Retinopathy Trial in Cairo (Intravitreal ranibizumab, Intravitreal
Recruiting
- Diabetic Macular Edema
- +3 more
- Intravitreal ranibizumab
- Intravitreal bevacizumab
-
Cairo, EgyptCairo University
Nov 26, 2021
Effect of Plasma Rich in Growth Factors on Semen Quality
Completed
- Vascular Endothelial Growth Factor Overexpression
- PRGF in candidates for sperm donors
-
Leioa, Vizcaya, Spain
- +2 more
Jul 29, 2022
Evaluation of New Biomarkers in Stage 3 and 4 Endometriosis
Completed
- Endometriosis
- endometriosis surgery
- other benign condition surgeries
-
Istanbul, Bagcilar, TurkeyBagcilar Teaching and Research Hospital
Mar 26, 2022
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Radiotherapy
- +4 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023
Obstructive Sleep Apnea Trial in Shatin (Continuous positive airway pressure (CPAP), Sham Continuous positive airway pressure
Completed
- Obstructive Sleep Apnea
- Continuous positive airway pressure (CPAP)
- Sham Continuous positive airway pressure (CPAP)
-
Shatin, New Territories, Hong KongThe Chinese University of Hong Kong
Jan 25, 2021
Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States
Completed
- Recurrent Fallopian Tube Carcinoma
- +2 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +44 more
Jan 10, 2022
Intermittent Claudication, Arteriosclerosis Trial in Birmingham, Bethesda, Madison (DNA Plasmid Vector, EW-A-401 DNA Plasmid
Completed
- Intermittent Claudication
- Arteriosclerosis
- DNA Plasmid Vector
- EW-A-401 DNA Plasmid Vector
-
Birmingham, Alabama
- +2 more
Dec 11, 2019
Diabetic Macular Edema, Cataract Trial in Shanghai (Lucentis)
Unknown status
- Diabetic Macular Edema
- Cataract
-
Shanghai, Shanghai, ChinaChanghai Hospital
Mar 25, 2020
Perioperative Hemodynamic and Microcirculatory Physiological
Not yet recruiting
- Aortic Valve Stenosis
- Determination of arterial compliance using blood pressure waveform analysis
- +6 more
- (no location specified)
Dec 1, 2023
Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham
Not yet recruiting
- Neovascular Age-related Macular Degeneration (nAMD)
- AR-14034 SR implant lower dose
- +3 more
- (no location specified)
Mar 3, 2023
Uterine Leiomyomas Trial (general anesthesia and patient controlled intravenous analgesia, spinal anesthesia and continuous
Completed
- Uterine Leiomyomas
- general anesthesia and patient controlled intravenous analgesia
- spinal anesthesia and continuous postoperative epidural analgesia
- (no location specified)
Jan 21, 2020
EGFR Exon 19 Deletion Mutation, EGFR NP_005219.2:p.L858R, Lung Non-Squamous Non-Small Cell Carcinoma Trial in United States
Completed
- EGFR Exon 19 Deletion Mutation
- +3 more
- Bevacizumab
- +3 more
-
La Jolla, California
- +18 more
Sep 16, 2020
Cardiac Complication, Vascular Diseases Trial in Paris (Cardiac complication induced by VEGF/VEGFR inhibitor)
Completed
- Cardiac Complication
- Vascular Diseases
- Cardiac complication induced by VEGF/VEGFR inhibitor
-
Paris, FranceAP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
Sep 24, 2019
Focal Laser Single Intravitreal Ranibizumab Retinal Artery
Completed
- Retinal Artery Macroaneurysm
- Dual focal laser and intravitreal Ranibizumab injection
-
Cairo, EgyptKasr alainy faculty of medicine
Jan 29, 2023
Healthy Trial in Norman (Fluconazole 150 mg)
Recruiting
- Healthy
- Fluconazole 150 mg
-
Norman, OklahomaDepartment of Health and Exercise Science
May 16, 2022
Acute Ischemic Stroke Trial in Beijing (iEPCs, Clinical standard treatment (CST))
Not yet recruiting
- Acute Ischemic Stroke
- iEPCs
- Clinical standard treatment (CST)
-
Beijing, Beijing, ChinaAllife
Aug 14, 2023
Insulin Resistance Trial in Poznan (the group GS (probiotic), the group GP ())
Completed
- Insulin Resistance
- the group GS (probiotic)
- the group GP (placebo)
-
Poznań, PolandPoznan University of Physical Education
Oct 13, 2023
Neovascular (Wet) Age-related Macular Degeneration (nAMD) Trial (EXG102-031)
Not yet recruiting
- Neovascular (Wet) Age-related Macular Degeneration (nAMD)
- EXG102-031
- (no location specified)
Jun 13, 2023
Inverted Papilloma, Molecular Fluorescence Imaging Trial in Groningen (Bevacizumab-800CW)
Active, not recruiting
- Inverted Papilloma
- Molecular Fluorescence Imaging
-
Groningen, NetherlandsUniversity Medical Center Groningen
Apr 30, 2021